Weight restoration in a patient with anorexia nervosa on dialysis.
OBJECTIVE
We report a case of weight restoration in a patient with anorexia nervosa, end-stage renal disease (ESRD) requiring dialysis, and cardiac insufficiency.


METHODS
The technical challenges and ethical issues involved in her clinical management are reviewed. Renal insufficiency is a common complication of more severe anorexia nervosa.


RESULTS
Progression to renal failure, when it occurs, is most typically a terminal event. There are currently no published guidelines for monitoring the weight gain of patients undergoing dialysis.


CONCLUSIONS
We present a case of a patient who progressed from renal insufficiency to renal failure while in treatment for anorexia nervosa, and who was ultimately successfully weight restored while on renal dialysis.
Woodside
D Blake
DB
Program for Eating Disorders, Department of Psychiatry, University of Toronto, Toronto, Canada. b.woodside@utoronto.ca
Colton
Patricia
P
Staab
Randolf
R
Schreiber
Martin
M
Sutandar-Pinnock
Kalam
K
Poynter
Brittany
B
Sacevich
Tegan
T
D000328:Adult; D000856:Anorexia Nervosa / Q000150:complications / Q000523:psychology / Q000628:therapy*; D001241:Aspirin / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D015992:Body Mass Index; D001835:Body Weight; D002110:Caffeine / Q000009:adverse effects; D003131:Combined Modality Therapy; D015897:Comorbidity; D003299:Cooperative Behavior; D003404:Creatinine / Q000097:blood; D004338:Drug Combinations; D005260:Female; D006333:Heart Failure / Q000523:psychology / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000523:psychology / Q000628:therapy*; D010348:Patient Care Team; D011615:Psychotherapy, Group; D012008:Recurrence; D006435:Renal Dialysis / Q000523:psychology; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology; D016896:Treatment Outcome; D016312:Treatment Refusal / Q000523:psychology; D014883:Water-Electrolyte Imbalance / Q000150:complications / Q000523:psychology / Q000628:therapy
D001463:Barbiturates; D004338:Drug Combinations; D002110:Caffeine; C001220:aspirin, butalbital and caffeine drug combination; D003404:Creatinine; D001241:Aspirin